Simultaneously, Supreme Court Clarifies and Clouds The Issue of New Versus Invention in § 101 Patent Eligibility Isolated DNA not an “invention” under 35 U.S.C. § 101 and not patent eligible cDNA is patent eligible [...]
Bifurcated patent trials may benefit defendants to the detriment of patent holders; trade-off may be larger damage awards in some cases. Federal Circuit rules that a judgment on patent infringement liability is appealable as a [...]
Federal Circuit, though divided, creates momentum toward resolution of the patent eligibility of software with these takeaways: Being “new and useful” are not enough for software patent eligibility: the question is whether “new and useful” [...]